Skip to main content

Whole Exome Sequencing Market On Present State & Future Growth Prospects to 2027: Illumina, Centogene, F. Hoffmann-La Roche AG, Psomagen, Pacific Biosciences of California

Press release   •   Sep 23, 2019 15:12 IST

Whole Exome Sequencing Market

The market is driven by the factors such as, reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery are likely to drive the growth of the whole exome sequencing market. However, ethical, social and legal concerns for whole exome sequencing and dearth of highly skilled professionals may restrict the growth of whole exome sequencing market.

As the whole sequencing techniques reduced time and cost for the analyzing genetic, it also offers a reduction of time spent in the trial and error for the drug formulation. The technique offers precise ability to measure the genetic variation among humans and their biological samples. Pharmaceutical companies influence this technology to fine-tune the germline genome to stabilize which, in return, enable then to buy an insurance policy during the presentation of initial findings to the FDA for the early stage approvals.

Get Sample PDF Copy at

The next-generation sequencing has enabled higher results of the analysis for genotypic and phenotypic relations among the human populations, helping in the development of genetics information for the drug development. In various human diseases are caused or are influenced by the genetic factors which provide important information about the diseases and thus help in the discovery of a novel drug.

Whole Exome Sequencing – MARKET SEGMENTATION

Global Whole Exome Sequencing Market – By Product & Service

  • Systems
  • Kits
  • Services
    • Sequencing Services
    • Data Analysis (Bioinformatics)
    • Other Services

Global Whole Exome Sequencing Market – By Technology

  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Other Technologies

Global Whole Exome Sequencing Market – By Application

  • DiagnosticsCancer Diagnostics
    • Monogenic (Mendelian) Disorders Diagnostics
    • Monogenic Types of Diabetes Diagnostics
    • HIV Diagnostics
    • Other Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Others

Buy Complete Report at

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.